Trial Profile
Patient Outcomes With Periarticular Liposomal Bupivacaine Injection vs Adductor Canal Block After Primary Total Knee Arthroplasty
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2020
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary) ; Ropivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 05 Oct 2020 Status changed from active, no longer recruiting to completed.
- 11 Sep 2019 Planned number of patients changed from 250 to 50.
- 11 Sep 2019 Planned End Date changed from 1 Jun 2018 to 1 Dec 2019.